Table 3.

Resveratrol, 8-pCPT-2′-O-Me-cAMP, and rolipram decrease hCB-EC permeability

Treatment	Permeability Percent Decrease
Resveratrol
20 μM	28 ± 7*
2 μM	41 ± 5*
8-pCPT-2′-O-Me-cAMP
100 μM	26 ± 5†
Rolipram
25 μM	30 ± 1†

Data are means ± SE; n = 3. *P < 0.05 and †P < 0.01 relative to the untreated control.